The business impacts of COVID-19 are far reaching and include transfer pricing considerations for multinational companies that should be actively managed and monitored. Companies and their transfer pricing specialists are dealing with a complex landscape that includes the potential effects of the pandemic on business strategies and resulting transfer pricing implications, changing market behaviors and the impacts on intercompany contracts and arrangements, adopting a different transfer pricing policy than what is contained in current agreements, and much more.